Recurrent hepatitis C after liver transplantation: Clinical and therapeutical issues

Journal of Viral Hepatitis

Volumn 7, Issue 2, 2000, Pages 87-92

  Samuel, D ^a   Feray, C ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Hepatitis; Hepatitis C virus; Liver transplantation

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; HLA ANTIGEN; IMMUNOGLOBULIN; INTERFERON; LIVER ENZYME; RIBAVIRIN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

CLINICAL TRIAL; GENOTYPE; GRAFT FAILURE; HEPATITIS C; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURVIVAL; VIRUS REPLICATION;

AGE FACTORS; GENOTYPE; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HUMANS; LIVER TRANSPLANTATION; SURVIVAL RATE;

EID: 0034125485     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00202.x     Document Type: Review

References (53)

1. 1 Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. In: Terasaki PI, Cecka JM, eds. Clinical Transplants 1996. Los Angeles: UCLA Tissue Typing Laboratory, 1997: 15-30.
2. 2 Bisceglie D. Liver transplantation for hepatitis C: the promise and the challenge. Hepatology 1995; 22: 660-662.
3. 3 Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. Clin Transpl 1995; 1: 19-33.
4. 4 Feray C, Samuel D, Thiers V et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89: 1361-1365.
5. 5 Gane E, Portmann BC, Naoumov NV et al. Long-term outcome of hepatitis C virus infection after liver transplantion. N Engl J Med 1996; 334: 815-820.
6. 6 Wright TL, Donegan E, Hsu H et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317-322.
7. 7 Chazouillères O, Kim M, Ferrel L et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994; 106: 994-999.
8. 8 Féray C, Gigou M, Samuel D et al. The course of hepatitis C infection after liver transplantation. Hepatology 1994; 20: 1137-1143.
9. 9 Lim H, Lau G, Davis G, Dolson D, Lau J. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C infection. Gastroenterology 1994; 106: 248-251.
10. 10 Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell ID. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg 1998; 4: 304-310.
11. 11 Charlton M, Seaberg E, Wiesner R et al. Predictors of patient and graft survival following liver transplantation for hepa. titis C. Hepatology 1998; 28: 823-830.
12. 12 Gane EJ, Naoumov NV, Qian KP et al. A longitudinal analysis of hepatitis C virus replication following liver trans-plantation. Gastroenterology 1996; 110: 167-177.
13. 13 Di Martino V, Saurini F, Samuel D et al. Long-term longitu-dinal study of intrahepatic hepatitis C virus replication after liver transplantation. Hepatology 1997; 26: 1343-1350.
14. 14 Gretch DR, Bacchi CE, Corey L et al. Persistent hepatitis C virus infection after liver transplantation: clinical and viro-logical features. Hepatology 1995; 22: 1-9.
15. 15 Féray C, Gigou M, Samuel D et al. Influence of the genotypes on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1089-1097.
16. 16 Zein NN, Rakela J. Poterucha JJ. Steers JL, Wiesner RH, Persing DH. Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up. Liver Transpl Surg 1995; 1: 354-357.
17. 17 Pageaux GP, Ducos J, Mondain AM et al. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplant recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection. Liver Transpl Surg 1997; 3: 501-505.
18. 18 Shuhart M, Bronner M, Gretch D et al. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997; 26: 1646-1652.
19. 19 Gordon FD, Poterucha JJ. Germer J et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63: 1419-1423.
20. 20 Costes V, Durand L, Pageaux GP et al. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C. Am J Clin Pathol 1999; 111: 252-258.
21. 21 Berg T, Hopf U, Bechstein WO et al. Pretransplant virological markers, hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation. Transplantation 1998; 66: 225-228.
22. 22 Vargas HE, Laskus T, Wang LF et al. The influence of hepatitis C virus genotypes on the outcome of liver transplan-tation. Liver Transpl Surg 1998; 4: 22-27.
23. 23 Boker KH, Dalley G, Bahr MJ et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25: 203-210.
24. 24 Zhou S, Terrault NA, Ferrell L et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041-1046.
25. 25 Prieto M, Berenguer M, Rayon JM et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-256.
26. 26 Sullivan DG, Wilson JJ, Carithers RL Jr, Perkins JD, Gretch DR. Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns. J Virol 1997; 72: 10036-10043.
27. 27 Yun Z, Barkholt L, Sonnerborg A. Dynamic analysis of hepatitis C virus polymorphism in patients with orthotopic liver transplantation. Transplantation 1997; 64: 170-172.
28. 28 Martell M, Esteban JI, Quer J et al. Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol 1994; 68: 3425-3436.
29. 29 Coller SJ, Gaur LK, Gretch DR et al Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation. Tissue Antigens 1998; 52: 435-443.
30. 30 Charco R, Vargas V, Allende H et al. Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection? Transpl Int 1996; 9 (suppl 1): S195-S197.
31. 31 Rozen HR, Shackleton CR, Higa L et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastromterol 1997; 92: 14453-14457.
32. 32 Rosen HR, Martin P. OKT3 and hepatitis C: defining the risks. Transplantation 1997; 63: 171-172.
33. 33 Ghobrial RM, Farmer DG, Baquerizo A et al Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-3'ear single-center experience. Ann Surg 1999; 229: 824-831; discussion 831-833.
34. 34 Zervos XA, Weppler D, Fragulidis GP et al. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. Transplantation 1998; 65: 1044-1046.
35. 35 Feray C, Samuel D, Gigou M et al. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection. Hepatology 1995; 22: 1084-1089.
36. 36 Wright TL, Combs C, Kim M et al. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 773-779.
37. 37 Gane EJ, Lo SK, Riordan SM et al. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998; 27: 1403-1407.
38. 38 Singh N, Gayowski T, Wannstedt CF et al. Interferon alfa for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation 1998; 65: 82-86.
39. 39 Bizollon T, Palazzo U, Ducerf C et al. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology 1997; 26: 500-504.
40. 40 Pham HP, Feray C, Samuel D et al Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 1998; 54: 1311-1319.
41. 41 Caccamo L, Colledan M, Rossi G et al. Post-hepatitis primary disease does not influence 6-year survival after liver transplantation beyond 1 year. Transpl Int 1998; 11 (suppl 1): S212-S220.
42. 42 Prieto M, Berenguer M, Rimola A et al. Liver transplantation in hepatitis C. A Spanish multi-centre experience. Eur J Gastroenterol Hepatol 1998; 10: 771-776.
43. 43 Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998; 66: 1612-1616.
44. 44 Sheiner PA, Schluger LK, Emre S et al. Retransplantation for recurrent hepatitis C. Liver Transpl Surg 1997; 3: 130-136,
45. 45 Feray C, Gigou M, Samuel D et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998: 128: 810-816.
46. 46 Shimizu YK, Igarashi H, Kiyohara T et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996; 223: 409-412.
47. 47 Farci P, Shimoda A, Wong D et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996; 93: 15394-15399.
48. 48 Krawczynski K, Alter MJ, Tankersley DL et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996; 173: 822-828.
49. 49 Candinas D, Joller-Jemelka HI, Schlumpf R et al. Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation. Med Microbiol 1994; 41: 220-223.
50. 50 Pereira BJ. Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Lancet 1995; 345: 484-187.
51. 51 Shah G, Demetris AJ, Irish W, Scheffel J, Mimms L, Van Thiel DH. Frequency and severity of HCV infection following orthotopic liver transplantation. Effect of donor and recipient serology for HCV using a second generation ELISA test. J Hepatol 1993; 18: 279-283.
52. 52 Vargas HE, Laskus T, Wang LF et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999; 117: 149-153.
53. 53 Feray C, Shouval D, Samuel D. Will transplantation of an hepatitis C-infected graft improve the outcome of liver transplantation in HCV patients? Gastroenterology 1999; 117: 263-265.